About Wellytics Discovery

The team building Wellytics Discovery.

Scientists and operators out of Hyderabad, India (from genomics, machine learning and health systems) building India's clinico-genomic foundation for discovery.

Genome readout
Interpreted
RARE VARIANT
BRCA1 c.68_69del
Pathogenic
POLYGENIC RISK
Breast cancer · top 4%
PHARMACOGENOMICS
CYP2D6 · poor metabolizer
ANCESTRY
South Asian · under-catalogued
Feeds a 1,200,000-patient cohort · population-scale
CANDIDATE TARGET
GENE-7q21
DRUGGABLE
Genome-wide significant · p = 3×10⁻¹²
Genotype +
Phenotype +
1,200,000
deeply-phenotyped patients · cohort assembled

Team

A team of scientists and operators.

Dheeraj Reddy Bobbili

Founder & CEO

PhD in genomics and bioinformatics, University of Luxembourg. Has worked on several large-scale projects in epilepsy and Parkinson's disease genomics.

Veera M. Rajagopal

Chief Scientific Officer

MD-PhD, physician-scientist. Formerly of the Regeneron Genetics Center, with deep expertise in genomics-driven drug discovery.

Sandeep Mamidi

Chief Operating Officer

Leads hospital-network operations and partnerships, 20+ institutions onboarded, and runs programmes with state governments.

And the team behind them

4

AI Engineers

3

Bioinformaticians

2

Geneticists

5

Software Developers

2

Data Scientists

3

Clinicians